We have a library of webinars that provide expert insights on pharmacy benefits
Specialty medications continue to reshape pharmacy benefit costs, even as GLP-1s dominate much of the conversation. Immunology and oncology remain among the highest-cost drug categories for plan sponsors, driven by new therapies with six-figure annual price tags, rising inflammatory drug …
GLP‑1 medications have moved far beyond diabetes management—reshaping obesity care, pharmacy practice, and the broader healthcare marketplace. But with rapid innovation comes increasing complexity, regulatory scrutiny, and clinical risk.
The pharmacy landscape continues to evolve at a pace that challenges even the most prepared employers. Rising specialty drug costs, shifting industry dynamics, and new regulatory actions will redefine how organizations approach their pharmacy benefits strategies in 2026.
Health care legislation is constantly evolving—from compliance requirements to PBM (pharmacy benefit manager) reform. But the complexity doesn’t have to be overwhelming. This session is about simplifying the complex so we can have a real conversation about what these changes …
We’ll review common PBM clinical programs like formulary management, prior authorization, and step therapy; discuss how to accurately assess PBM program performance; identify ways to measure cost savings and financial impact; and highlight innovative solutions to maximize value for plan …
We’ll review common PBM clinical programs like formulary management, prior authorization, and step therapy; discuss how to accurately assess PBM program performance; identify ways to measure cost savings and financial impact; and highlight innovative solutions to maximize value for plan …
